Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN TUMOR NECROSIS FACTOR ALPHA, AND USE THEREOF

No-Receipt date 2019-01617 - 22/04/2019
No-Filing date 20190800021 - 22/04/2019
No-Granting date -
No-EPO application date -
No-EPO granting date -
Gazette No-Publication date of application 8/2019 - 25/09/2019
Gazette No-Publication date of granted patent -
Expiration date 07/10/2024
Kind of title Supplementary Protection Certificate for Medicinal Products
Legal status NOT VALID
Priorities GB001381006/06/2000/GB
Active Substance of Supplementary Certificates CERTOLIZUMAB

IPC Classification

Related Documents

Related Titles
TypeMaster titleRelated title
[SPC] 20190400279

Owners
CodeFirstnameSurnameAddressTownZIPCountry
965189 UCB PHARMA, S.A. ALLEE DE LA RECHERCHE 601070 BRUXELLES BELGIUM

Inventors
CodeFirstnameSurname
2416278 ATHWAL, DILJEET SINGH
2416279 BROWN, DEREK THOMAS
2416280 WEIR, ANDREW NEIL CHARLES
2416281 POPPLEWELL, ANDREW GEORGE
2416282 CHAPMAN, ANDREW PAUL
2416283 KING, DAVID JOHN

Representatives
CodeFirstnameSurnameAddressTownZip
3089NIKOLAOSLYMPERIS "DIKIGORIKI ETAIREIA VAGIANOU KOSTOPOULOU LYMPERI"STOURNARI 37ATHINA (ATTIKIS)10682

Contact
CodeFirstnameSurnameAddressTownZipCountry
7915NIKOLAOSLYMPERISSTOURNARI 37ATHINA (ATTIKIS)10682 GREECE

Owners History

Title Instruments
DateOperationDescreption
10/31/2019 12:00:00 AMΓενική Παραίτηση (7g400) Με την αίτηση αριθμ. πρωτ. 11454/21-10-2019/ΔΝΥ1552/22-10-2019 ο πληρεξούσιος δικηγόρος κ. Νικόλαος Λυμπέρης της Δικηγορικής εταιρείας Βαγιανού-Κωστοπούλου-Λυμπέρη, υπέβαλε αίτηση ΠΑΡΑΙΤΗΣΗΣ

Payments history
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015
 
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).